Study to Evaluate a Contact Lens Lubricating and Rewetting Drop
NCT ID: NCT01267656
Last Updated: 2020-09-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
168 participants
INTERVENTIONAL
2010-10-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops
NCT05814367
An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular Dryness
NCT01132287
Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Eye Ointment
NCT01076998
A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop
NCT04175340
A Study to Evaluate the Safety and Efficacy of a New Silicone Hydrogel Contact Lens Design
NCT01449526
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lubricating and Rewetting Drops
Lubricating and Rewetting Drops, after one week of using the first rewetting drops, the subjects will return for an exam and crossover to the second rewetting drops for one week.
Lubricating and Rewetting Drops
Instill 1-2 rewetting drops in each eye at least QID (4 times per day) for one week.
AMO Blink Contacts Lubricant Eye Drops
AMO Blink Contacts Lubricant Eye Drops, After one week of using the first rewetting drops, the subjects will return for an exam and crossover to the second rewetting drops for one week
AMO Blink Contacts Lubricant Eye Drops
Instill 1-2 rewetting drops in each eye at least QID (4 times per day) for one week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lubricating and Rewetting Drops
Instill 1-2 rewetting drops in each eye at least QID (4 times per day) for one week.
AMO Blink Contacts Lubricant Eye Drops
Instill 1-2 rewetting drops in each eye at least QID (4 times per day) for one week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
* Use a lens care system on a regular basis.
* Wear their habitual lenses (or be willing to wear lenses) a minimum of 8 hours per day.
* Willing to use drops 4 times per day.
Exclusion Criteria
* An active ocular disease, any corneal infiltrative response, or are using any ocular medications.
* Any scar or neovascularization within the central 4mm of the cornea.
* Any grade 2 or greater finding during the slit lamp examination
* Using any systemic or topical medications that will affect ocular physiology or lens performance.
* Aphakic.
* Amblyopic.
* Allergic to any component in the study care products.
* Have had any corneal surgery.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephanie Su, OD
Role: PRINCIPAL_INVESTIGATOR
Bausch & Lomb Incorporated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bausch & Lomb
Rochester, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
684E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.